|
|
News Breaks | | | | February 25, 2013 | | 09:58 EDT |  | AMGN | Amgen edges new high, fades, levels to watch
Shares are up over 4.2%, but this is a fade from earlier highs at $91.25, a new high for the shares. Support is currently at $89.58. | |
|
News For AMGN From The Last 14 Days Check below for free stories on AMGN the last two weeks. |
|
|
| May 13, 2013 | | 08:55 EDT |  | AMGN | Biosimiliar drug bill to be taken up in Senate, LA Times reports
 Subscribe for More Information | | | May 9, 2013 | | 16:48 EDT |  | AMGN | Amgen, Zhejiang Beta Pharma announce joint venture in China
Subscribe for More Information | | | May 7, 2013 | | 16:31 EDT | | AMGN | Amgen announces Phase 3 head-to-head study of Vectibix versus Erbitux
Subscribe for More Information | | | May 6, 2013 | | 07:01 EDT | | AMGN | Transgenomic, Amgen sign collaboration agreement for CE-IVD CRC RAScan tests
Subscribe for More Information | |
|
|
|
|
|
|
